MusclePharm(NYSE:R) Corporation (OTCBB:MSLP), one of the fastest growing nutritional supplement companies in the United States with a proprietary formulation used in eight performance products, recently disclosed that Bodybuilding.com selected MusclePharm as the Supplement Company of the Month for October.
"We are extremely pleased Bodybuilding.com is recognizing MusclePharm for our accomplishments and growing, loyal customer base by featuring us as the Supplement Company of the Month," commented Brad Pyatt, MusclePharm's Chief Executive Officer. "MusclePharm's brand awareness and market penetration has increased substantially in a very short period of time due to our products scientific development and the backing of some of the most influential people in the fitness and sports nutrition world."
Headquartered in Denver, Colorado, MusclePharm is a rapidly expanding healthy life-style company that developments and manufacturers a full line of NSF and scientifically approved, nutritional supplements that are 100% free of any banned substances. Based on years of research, MusclePharm products are created through an advanced six-stage research protocol involving the expertise of top nutritional scientists and field tested by more than 100 elite professional athletes from various sports including the NFL, MMA, and MLB. MusclePharm's propriety and award winning products address all categories of an active lifestyle including muscle building, weight loss, and maintaining general fitness through a daily nutritional supplement regimen. MusclePharm is sold in over 120 countries and available in over 5,000 US retail outlets that include GNC, and Vitamin Shoppe, as well as over 100 online stores, including bodybuilding.com, Amazon and Vitacost.com.
wallstreetequityresearch.com brings investors market knowledge on the aspects moving the general entertainment stocks, and offers complete analytical research on companies like Carnival Corporation (NYSE: CCL) and Royal Caribbean Cruises Ltd.. While the economic downturn continues to disrupt businesses and sectors alike, cruise ship companies have been posting strong gains this summer. Though it may come as a surprise that general entertainment companies are doing well as companies selling more essential products are struggling, there are a number of reasons for it.
Carnival Corporation operates as a cruise and vacation company in the United States and internationally.
Hedge fund manager William Ackman has taken a large stake in retailer J. C. Penney Company, Inc. (NYSE: JCP) through his Pershing Square Capital Management Company. Ackman, who has a history of activist investing, considers the department store chain undervalued. Ackman didn't detail specific plans for change at Penney, but indicated areas of interest. Ackman's firm took a 16.5% stake in Penney and a 10.9% stake in Fortune Brands, with its unwieldy cobbled together portfolio of holdings from Jim Beam whiskey to Titleist golf balls. Disclosures of Ackman's stakes through Pershing Square were revealed in 13D filings for the Securities and Exchange Commission. Ackman has previously taken large stakes in Borders Group, Sears Holdings, as well as other notable retailers.
J. C. Penney Company, Inc., through its subsidiary, J. C. Penney Corporation, Inc., operates a network of department stores in the United States and Puerto Rico. J. C. Penney sells family apparel and footwear, accessories, fine and fashion jewelry, beauty products, and home furnishings.
Macy's, Inc. (NYSE: M) reported four major strides in its ongoing drive to reduce energy consumption and waste as part of the Macy's comprehensive program of sustainability and operating efficiency.
Macy's, Inc., with corporate offices in Cincinnati and New York, is one of the nation's premier retailers, with fiscal 2009 sales of $23.5 billion. Macy's operates about 850 department stores in 45 states, the District of Columbia, Guam and Puerto Rico under the names of Macy's and Bloomingdale's, as well as the macys.com and bloomingdales.com websites.
Sign-Up For Free Stock Alerts At http://crwepicks.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.The CRWEPicks.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer ( http://crwepicks.com/disclaimer ) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEPicks.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. ( read more ) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period. The fee may be in cash, in free trading stock, in restricted stock, or in any combination thereof. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings, Inc. (OTCPK:CRWE) has received twenty five thousand dollars in cash and seventy five thousand free trading shares from a third party (Bishop Equity Partners) for (30) days of advertising for Muscle Pharm Corp. (OTCQB:MSLP).